System and method for detecting pulmonary edema based on impedance measured using an implantable medical device during a lead maturation interval
AssigneePacesetter, Inc.
InventorsAjit Pillai, Cecilia Qin Xi
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsAjit Pillai, Cecilia Qin Xi
Estimating the term…
Techniques are provided for use by implantable medical devices such as cardiac resynchronization therapy (CRT) devices for detecting pulmonary edema based on transthoracic impedance sensed using cardiac pacing/sensing leads, wherein detection can be performed while lead maturation occurs. Briefly, the implantable device determines whether the leads are within an initial post-implant interval following implant during which lead maturation generally occurs. The device then detects pulmonary edema or related medical conditions within the patient based on transthoracic impedance using a set of detection parameters adjusted for use during the post-implant interval. Thus, rather than “blanking” impedance data during lead maturation, the device instead detects and processes impedance during this period to identify possible episodes of pulmonary edema so that appropriate measures can be undertaken, such as delivery of warnings or titration of appropriate medications.
A method for use with an implantable medical device for implant within a patient along with at least one lead, the method comprising:
A system for use with an implantable medical device for implant within a patient along with at least one lead, the system comprising:
The system for use with an implantable medical device for implant within a patient along with at least one lead, the system comprising:
Dependencies are inferred from the claim text.